HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MABWELL-B

20.700

+0.0600.29%

Volume:829.60K

Turnover:17.23M

Market Cap:9.25B

PE:-8.52

High:21.400

Open:21.000

Low:20.540

Close:20.640

52wk High:31.460

52wk Low:19.860

Shares:447.00M

HK Float Shares:47.13M

Volume Ratio:8.26

T/O Rate:1.76%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.430

ROE:-91.76%

ROA:-10.46%

PB:9.07

PE(LYR):-8.52

PS:9.07

Loading ...

Overview Company News Filings

Mabwell to Present Latest Clinical Data for ADC 9MW2821 at 2026 ASCO Annual Meeting

Mabwell Gets Chinese Regulatory Nod to Expand Indication of Denosumab

MT Newswires Live

Mabwell's Injection Gains Approval for Expanded Use in Bone Metastasis and Multiple Myeloma Treatment

Mabwell Gets FDA Clearance for Inflammatory Bowel Disease Drug

MT Newswires Live

Mabwell-B Shares Surge Following FDA Clearance for Clinical Trial of Novel Drug Candidate

Mabwell Receives FDA Clearance for Clinical Trial of 9MW5211 Injection

Mabwell Bioscience Reports No Share Capital Changes in First Post-Listing Monthly Return

Bulletin Express

Mabwell (Shanghai) Bioscience Sets 1 June 2026 EGM to Approve Up to RMB1.00 Billion Targeted Debt Financing

Bulletin Express

Mabwell Announces Transition to Electronic Delivery of Corporate Communications

Bulletin Express

Mabwell seeks NAFMII nod for targeted debt financing of up to RMB1.00 billion

Bulletin Express

Mabwell to Implement Fully Digital Distribution of Shareholder Communications from 6 May 2026

Bulletin Express

MABWELL-B Plans to Issue Up to 1 Billion Yuan in Private Debt Financing Instruments

Mabwell Receives HKEX Waiver From Issuing Separate 2025 Annual Report

Bulletin Express

Mabwell’s 2025 ESG Report Highlights 147% Jump in R&D Investment and Marked Decline in Carbon Intensity

Bulletin Express

MABWELL-B Shares Surge Over 23% to Record High in Early Trading, Four Products Approved for Market

Mabwell-B Shares Surge Over 23% on Promising Cervical Cancer Drug Data Timeline

Stock Track | Mabwell Bio Soars 6.44% Intraday on Strong Q1 Revenue Growth and Stock Connect Inclusion

Stock Track | MABWELL-B Soars 5.21% in Intraday Trading on Strong IPO Demand and Higher Opening Price

Mabwell-B Fixes HK IPO Price at HK$27.64, Secures HK$1.19 Billion Net Proceeds

Bulletin Express

MABWELL-B Added to Shanghai-Hong Kong Stock Connect Program

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/02493/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02493","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02493\",,,,,undefined,":{"symbol":"02493","market":"HK","secType":"STK","nameCN":"MABWELL-B","latestPrice":20.7,"timestamp":1790755706074,"preClose":20.64,"halted":0,"volume":829600,"delay":0,"changeRate":0.0029069767441859845,"floatShares":47130200,"shares":447000000,"eps":-2.43,"marketStatus":"Closed National Day","change":0.06,"latestTime":"09-30 16:08:26","open":21,"high":21.4,"low":20.54,"amount":17234816,"amplitude":0.041667,"askPrice":20.86,"askSize":800,"bidPrice":20.58,"bidSize":4600,"shortable":0,"etf":0,"ttmEps":-2.422,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1777305600000,"exchange":"SEHK","adjPreClose":20.64,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":8.259657516837505,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688062","market":"SH","secType":"STK","nameCN":"Mabwell(Shanghai)Bioscience Co.,Ltd.","latestPrice":27.04,"timestamp":1790751600000,"preClose":26.01,"halted":0,"volume":8947700,"delay":0,"premium":"-34.45"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02493\",,,,,undefined,":{"symbol":"02493","floatShares":47130200,"roa":"-10.46%","roe":"-91.76%","lyrEps":-2.43,"volumeRatio":8.259657516837505,"shares":447000000,"dividePrice":0,"high":21.4,"amplitude":0.041667,"preClose":20.64,"low":20.54,"week52Low":19.86,"pbRate":"9.07","psRate":"9.07","week52High":31.46,"institutionHeld":0,"latestPrice":20.7,"committee":0.703704,"eps":-2.43,"divideRate":0,"volume":829600,"delay":0,"ttmEps":-2.422,"open":21,"prevYearClose":27.64,"prevWeekClose":21.18,"prevMonthClose":20.7,"prevQuarterClose":20.7,"fiveDayClose":21.08,"twentyDayClose":20.78,"sixtyDayClose":22.8,"earningDate":1793203200000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02493\",params:#limit:5,,,undefined,":[{"date":"2026-10-29","symbol":"02493","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1793237400000,"name":null,"time":"","dateTimestamp":1793203200000,"actualEps":null},{"market":"HK","date":"2026-08-31","symbol":"02493","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1788105600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02493\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02493\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1783699200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02493\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02493","date":"2026-09-30","current":-8.546656,"percent":0.863636,"low":-17.302507,"twenty":-15.593679,"median":-13.948862,"eighty":-12.671261,"high":-11.071436,"avg":-14.08876,"sd":1.526689,"marketCap":13577984397.97},"quantilePoints":[{"date":"2026-04-24","current":-15.289641,"twenty":-16.199622,"median":-15.659552,"eighty":-15.437605,"marketCap":17000217748.15},{"date":"2026-04-30","current":-16.640195,"twenty":-16.379645,"median":-15.593679,"eighty":-15.250239,"marketCap":17562577595.07},{"date":"2026-05-08","current":-16.416983,"twenty":-16.631559,"median":-16.471868,"eighty":-15.350449,"marketCap":17380742435.69},{"date":"2026-05-15","current":-16.009725,"twenty":-16.685787,"median":-16.416983,"eighty":-15.606854,"marketCap":16994157190.87},{"date":"2026-05-22","current":-15.517615,"twenty":-16.631559,"median":-16.0746,"eighty":-15.529829,"marketCap":16434142933.1},{"date":"2026-05-29","current":-14.179755,"twenty":-16.597014,"median":-15.628209,"eighty":-15.240388,"marketCap":15069483633.31},{"date":"2026-06-05","current":-12.517432,"twenty":-16.559668,"median":-15.581594,"eighty":-14.26556,"marketCap":13322161865.15},{"date":"2026-06-12","current":-13.472006,"twenty":-16.526753,"median":-15.469041,"eighty":-13.356302,"marketCap":14328406594.37},{"date":"2026-06-18","current":-12.99766,"twenty":-16.438937,"median":-15.265014,"eighty":-12.92448,"marketCap":13857073336},{"date":"2026-06-26","current":-12.199681,"twenty":-16.378066,"median":-14.95714,"eighty":-12.901569,"marketCap":12942815528.08},{"date":"2026-07-03","current":-14.979824,"twenty":-16.23102,"median":-14.955208,"eighty":-12.918972,"marketCap":15904197681.19},{"date":"2026-07-10","current":-14.849801,"twenty":-16.061625,"median":-14.902504,"eighty":-12.970767,"marketCap":15746801597.92},{"date":"2026-07-17","current":-14.420221,"twenty":-16.08484,"median":-14.955208,"eighty":-13.013901,"marketCap":15345691723.29},{"date":"2026-07-24","current":-14.443737,"twenty":-16.025201,"median":-14.968482,"eighty":-13.071825,"marketCap":15374169818.76},{"date":"2026-07-31","current":-13.354051,"twenty":-15.926439,"median":-14.902504,"eighty":-13.105062,"marketCap":14241292067.7},{"date":"2026-08-07","current":-14.221458,"twenty":-15.744727,"median":-14.562278,"eighty":-13.056126,"marketCap":15195777985.44},{"date":"2026-08-14","current":-15.770582,"twenty":-15.789139,"median":-14.806347,"eighty":-13.105062,"marketCap":16872365889.11},{"date":"2026-08-21","current":-14.469039,"twenty":-15.760286,"median":-14.849801,"eighty":-13.131915,"marketCap":15514103639.81},{"date":"2026-08-28","current":-13.731399,"twenty":-15.716499,"median":-14.541981,"eighty":-13.197968,"marketCap":14726523718},{"date":"2026-09-04","current":-12.516523,"twenty":-15.668212,"median":-14.452874,"eighty":-13.105062,"marketCap":13723599618.54},{"date":"2026-09-11","current":-11.071436,"twenty":-15.638845,"median":-14.399902,"eighty":-12.948913,"marketCap":12155532628.82},{"date":"2026-09-18","current":-12.176127,"twenty":-15.603417,"median":-14.26556,"eighty":-12.860017,"marketCap":13385859785.88},{"date":"2026-09-25","current":-12.13134,"twenty":-15.595591,"median":-14.072299,"eighty":-12.818568,"marketCap":13311206005.78},{"date":"2026-09-30","current":-12.351429,"twenty":-15.593679,"median":-13.948862,"eighty":-12.671261,"marketCap":13577984397.97}],"updateTime":1790835996280},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02493\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1187250283","title":"Mabwell to Present Latest Clinical Data for ADC 9MW2821 at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1187250283","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187250283?lang=en_us&edition=fundamental","pubTime":"2026-05-21 17:21","pubTimestamp":1779355318,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. has announced that it will present clinical data for its targeted Nectin-4 ADC novel drug, 9MW2821 (Bulumtatug Fuvedotin, BFv), at the 2026 American Society of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0239","02493","688062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637053928","title":"Mabwell Gets Chinese Regulatory Nod to Expand Indication of Denosumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2637053928","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637053928?lang=en_us&edition=fundamental","pubTime":"2026-05-21 11:16","pubTimestamp":1779333367,"startTime":"0","endTime":"0","summary":"Mabwell  Bioscience  said Chinese regulators expanded denosumab's approval to include new indications, according to a Wednesday filing with the Hong Kong bourse.The firm's Hong Kong shares gained nearly 4% in morning trade Thursday.Denosumab, also known as maiweijian and 9MW0321, will now be available to treat bone metastases from solid tumors and to delay or reduce the risk of skeletal-related events in patients with multiple myeloma.The medicine, a biosimilar version of Xgeva, was previously approved in China to treat giant cell tumor of the bone.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK0239","02493","688062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135264718","title":"Mabwell's Injection Gains Approval for Expanded Use in Bone Metastasis and Multiple Myeloma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1135264718","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135264718?lang=en_us&edition=fundamental","pubTime":"2026-05-20 16:40","pubTimestamp":1779266432,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) announced that its wholly-owned subsidiary, Jiangsu Taikang Biological Medicine Co., Ltd., has received approval from the National Medical Products...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688062","02493","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634477456","title":"Mabwell Gets FDA Clearance for Inflammatory Bowel Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2634477456","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634477456?lang=en_us&edition=fundamental","pubTime":"2026-05-11 14:20","pubTimestamp":1778480432,"startTime":"0","endTime":"0","summary":"Mabwell  Bioscience's  clinical trial application for 9MW521, a novel injection targeting Inflammatory Bowel Disease , was formally cleared by the US Food and Drug Administration, according to a May 8 Hong Kong bourse filing.Shares of the pharmaceutical firm were up nearly 4% in Monday afternoon trading.The drug will be tested as a treatment for inflammatory bowel disease.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LABU","02493","BK4588","IBD","BK1161","688062","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187988475","title":"Mabwell-B Shares Surge Following FDA Clearance for Clinical Trial of Novel Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1187988475","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187988475?lang=en_us&edition=fundamental","pubTime":"2026-05-11 14:00","pubTimestamp":1778479227,"startTime":"0","endTime":"0","summary":"Mabwell-B (02493) saw its shares rise nearly 5% in the afternoon session. At the time of writing, the stock was up 3.54%, trading at HKD 27.52 with a turnover of HKD 33.26 million. The increase...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","02493","BK1161","BK1574","BK4585","159992","VXUS","688062","06978","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120526047","title":"Mabwell Receives FDA Clearance for Clinical Trial of 9MW5211 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1120526047","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120526047?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:20","pubTimestamp":1778235634,"startTime":"0","endTime":"0","summary":"Mabwell (688062.SH) announced that it has received a Study May Proceed notification from the U.S. Food and Drug Administration (FDA), granting official approval for the clinical trial application of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493","BK1161","BK0239","BK4585","BK4588","688062","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108460780","title":"Mabwell Bioscience Reports No Share Capital Changes in First Post-Listing Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1108460780","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108460780?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:04","pubTimestamp":1778155467,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (abbrev. Mabwell Bioscience) has released its inaugural Monthly Return for the period ended 30 April 2026 following the company’s Main Board debut on the Hong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127675446","title":"Mabwell (Shanghai) Bioscience Sets 1 June 2026 EGM to Approve Up to RMB1.00 Billion Targeted Debt Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=1127675446","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127675446?lang=en_us&edition=fundamental","pubTime":"2026-05-06 23:02","pubTimestamp":1778079764,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (MABWELL-B) has called its 2026 second extraordinary general meeting (EGM) for 3:00 p.m. on Monday, 1 June 2026 at Conference Room 103, Building 3, Chuangxiang...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128854163","title":"Mabwell Announces Transition to Electronic Delivery of Corporate Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1128854163","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128854163?lang=en_us&edition=fundamental","pubTime":"2026-05-06 22:42","pubTimestamp":1778078579,"startTime":"0","endTime":"0","summary":"On 6 May 2026 Mabwell (Shanghai) Bioscience Co., Ltd. announced that all future corporate communications—including annual and interim reports, circulars, meeting notices and proxy forms—will be...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135676279","title":"Mabwell seeks NAFMII nod for targeted debt financing of up to RMB1.00 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1135676279","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135676279?lang=en_us&edition=fundamental","pubTime":"2026-05-06 22:42","pubTimestamp":1778078576,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. announced that its board approved an application to the National Association of Financial Market Institutional Investors (NAFMII) for the registration and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125424148","title":"Mabwell to Implement Fully Digital Distribution of Shareholder Communications from 6 May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1125424148","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125424148?lang=en_us&edition=fundamental","pubTime":"2026-05-06 22:22","pubTimestamp":1778077369,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. has announced that, with effect from 6 May 2026, all future corporate communications to shareholders will transition to electronic delivery in compliance with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126415861","title":"MABWELL-B Plans to Issue Up to 1 Billion Yuan in Private Debt Financing Instruments","url":"https://stock-news.laohu8.com/highlight/detail?id=1126415861","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126415861?lang=en_us&edition=fundamental","pubTime":"2026-05-06 22:12","pubTimestamp":1778076735,"startTime":"0","endTime":"0","summary":"MABWELL-B (02493) has announced its intention to apply for the registration and issuance of private debt financing instruments with a total value not exceeding 1 billion yuan (inclusive). The move...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688062","BK0239","BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161249506","title":"Mabwell Receives HKEX Waiver From Issuing Separate 2025 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1161249506","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161249506?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:23","pubTimestamp":1777551808,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. announced that Hong Kong’s Listing Rules will not require the company to publish an independent annual report or summary financial report for the financial...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169278363","title":"Mabwell’s 2025 ESG Report Highlights 147% Jump in R&D Investment and Marked Decline in Carbon Intensity","url":"https://stock-news.laohu8.com/highlight/detail?id=1169278363","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169278363?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:05","pubTimestamp":1777550725,"startTime":"0","endTime":"0","summary":"Mabwell (Mabwell-B) released its 2025 Environmental, Social and Governance (ESG) Report detailing significant progress across innovation, environmental management and stakeholder engagement. R&D...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162663926","title":"MABWELL-B Shares Surge Over 23% to Record High in Early Trading, Four Products Approved for Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1162663926","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162663926?lang=en_us&edition=fundamental","pubTime":"2026-04-30 11:41","pubTimestamp":1777520462,"startTime":"0","endTime":"0","summary":"MABWELL-B (02493) saw its shares rise more than 23% during early trading, reaching a peak of HK$31.46, marking a new record high since its listing. At the time of writing, the stock was up 7.22% to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1161","688062","BK0239","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141606847","title":"Mabwell-B Shares Surge Over 23% on Promising Cervical Cancer Drug Data Timeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1141606847","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141606847?lang=en_us&edition=fundamental","pubTime":"2026-04-30 10:56","pubTimestamp":1777517776,"startTime":"0","endTime":"0","summary":"Mabwell-B (02493) saw its shares surge more than 23%, reaching a record high of HK$31.46. At the time of writing, the stock was up 14.36% to HK$29.14, with a turnover of HK$140 million. The company...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688062","BK0239","BK4585","02493","BK4588","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109239943","title":"Stock Track | Mabwell Bio Soars 6.44% Intraday on Strong Q1 Revenue Growth and Stock Connect Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1109239943","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109239943?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:50","pubTimestamp":1777513802,"startTime":"0","endTime":"0","summary":"Mabwell Bio's stock price surged 6.44% during intraday trading on Thursday, marking a significant rebound in its share price.The sharp rise appears to be driven by the company's recently reported...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146067958","title":"Stock Track | MABWELL-B Soars 5.21% in Intraday Trading on Strong IPO Demand and Higher Opening Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1146067958","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146067958?lang=en_us&edition=fundamental","pubTime":"2026-04-28 09:39","pubTimestamp":1777340366,"startTime":"0","endTime":"0","summary":"MABWELL-B's stock soared 5.21% in intraday trading on Tuesday, marking a strong debut on the Hong Kong Stock Exchange.The significant price surge comes as the stock opened at HK$28.3 per share, which...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1182002319","title":"Mabwell-B Fixes HK IPO Price at HK$27.64, Secures HK$1.19 Billion Net Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=1182002319","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182002319?lang=en_us&edition=fundamental","pubTime":"2026-04-27 22:45","pubTimestamp":1777301130,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (stock short name “MABWELL-B”) has finalised the offer price for its Hong Kong listing at HK$27.64 per H share, generating approximately HK$1.19 billion in net...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157365623","title":"MABWELL-B Added to Shanghai-Hong Kong Stock Connect Program","url":"https://stock-news.laohu8.com/highlight/detail?id=1157365623","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157365623?lang=en_us&edition=fundamental","pubTime":"2026-04-27 21:14","pubTimestamp":1777295669,"startTime":"0","endTime":"0","summary":"On April 27, the Shanghai Stock Exchange issued a notice regarding adjustments to the list of eligible securities under the Shanghai-Hong Kong Stock Connect program. MABWELL-B (02493), the H-share...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02493","BK4585","688062","BK0239","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":73,"code":"91000000","status":"200"}]}}